Organogenesis Holdings Inc
NASDAQ:ORGO

Watchlist Manager
Organogenesis Holdings Inc Logo
Organogenesis Holdings Inc
NASDAQ:ORGO
Watchlist
Price: 4.47 USD -2.4% Market Closed
Market Cap: 567m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+60%
Revenue
Forecast
+6%
Operating Income
Forecast
+39%
Net Income
Forecast
N/A

Wall Street
Price Targets

ORGO Price Targets Summary
Organogenesis Holdings Inc

Wall Street analysts forecast ORGO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORGO is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

ORGO Lowest Forecast
Wall Street Target
7.07 USD
58% Upside
ORGO Average Forecast
Wall Street Target
7.14 USD
60% Upside
ORGO Highest Forecast
Wall Street Target
7.35 USD
64% Upside
Lowest
Price Target
7.07 USD
58% Upside
Average
Price Target
7.14 USD
60% Upside
Highest
Price Target
7.35 USD
64% Upside
Organogenesis Holdings Inc Competitors:
Price Targets
I
086890
Isu Abxis Co Ltd
86% Upside
H
301207
Hualan Biological Bacterin Inc
5% Upside
W
300142
Walvax Biotechnology Co Ltd
31% Downside
NRIX
Nurix Therapeutics Inc
217% Upside
I
086890
Isu Abxis Co Ltd
86% Upside
H
301207
Hualan Biological Bacterin Inc
5% Upside
W
300142
Walvax Biotechnology Co Ltd
31% Downside
NRIX
Nurix Therapeutics Inc
217% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
7% Downside
BIOPOR
Bioporto A/S
219% Upside
ORKA
Oruka Therapeutics Inc
172% Upside
VNDA
Vanda Pharmaceuticals Inc
186% Upside

Revenue
Forecast

Revenue Estimate
Organogenesis Holdings Inc

The compound annual growth rate of Organogenesis Holdings Inc's revenue for the next 3 years is 6%.

N/A
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Organogenesis Holdings Inc

The compound annual growth rate of Organogenesis Holdings Inc's operating income for the next 3 years is 39%.

N/A
Past Growth
39%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Organogenesis Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
What are analyst estimates?

See Also

Summary
ORGO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORGO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORGO stock valuation using valuation multiples.
Wall Street Estimates
ORGO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORGO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORGO's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for ORGO is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

What is Organogenesis Holdings Inc's Revenue forecast?
Projected CAGR
6%

The compound annual growth rate of Organogenesis Holdings Inc's revenue for the next 3 years is 6%.

What is Organogenesis Holdings Inc's Operating Income forecast?
Projected CAGR
39%

The compound annual growth rate of Organogenesis Holdings Inc's operating income for the next 3 years is 39%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 276,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.